{
  "id": 16754413,
  "title": "Marine molecule may help combat 'brain-eating' amoeba",
  "url": "https://urgent.news/2026/10/27/marine-molecule-may-help-combat-brain-eating-amoeba",
  "topic": "science",
  "section": "Science",
  "published": "2026-10-27T14:40:32.000Z",
  "source": {
    "name": "Phys.org",
    "slug": "phys-org",
    "url": "https://phys.org/news/2026-10-marine-molecule-combat-brain-amoeba.html"
  },
  "original_language": "en",
  "account": "Primary amoebic meningoencephalitis (PAM), caused by the amoeba Naegleria fowleri, is an extremely lethal brain infection with a 97% fatality rate. Researchers at the University of California San Diego have discovered a marine-derived compound, rutamycin B, that rapidly and effectively combats the parasite. Published in Marine Drugs, the study led by Debnath, Fenical, and doctoral candidate Hayley Fong found that rutamycin B demonstrates significant potency against multiple clinical N. fowleri strains at low concentrations, achieving full potency within four hours compared to 16 hours for amphotericin B, the current standard treatment. Amphotericin B often lags in efficacy or causes severe toxicity, but rutamycin B is 200-300 times more toxic to the amoeba than to human cells. The researchers are optimistic about rutamycin B's potential to cross the blood-brain barrier and effectively treat PAM; however, further animal model studies are required before clinical application.",
  "summary": "Primary amoebic meningoencephalitis (PAM), a parasitic disease that causes the rapid deterioration of brain tissue, is one of the most lethal infections known, with a fatality rate exceeding 97%. Caused by the free-living amoeba Naegleria fowleri (N. fowleri), the disease progresses with devastating speed, often leaving patients with only a few days to respond to treatment.",
  "key_points": [
    "Marine molecule rutamycin B combats brain-eating amoeba Naegleria fowleri.",
    "Study led by UC San Diego researchers finds rutamycin B effective at low concentrations.",
    "Rutamycin B 200-300 times more toxic to amoeba than to human cells."
  ],
  "editors_take": "Identifying a marine compound that targets the parasite more rapidly and with less human toxicity offers a potential shift toward safer, more effective treatments for lethal brain infections.",
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}